CATEGORIES
Results: 152

First Quarter COVID-19 Disclosure Examples – Part Five - Clorox

First Quarter COVID-19 Disclosure Examples – Part Four

CorpFin Issues Disclosure Guidance Topic 9A - Coronavirus (COVID-19) — Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources

Steve Explains Accounting Memes: Jim Halpert and the Sorting Hat

XBRL Xplained: Pranav Ghai of Calcbench

First Quarter COVID-19 Disclosure Examples – Part Three

Reasonably Equivalent Value: What Distressed-Asset Buyers Should Know

COVID-19 and Accounting for Loan Modifications

Recommendations for Fair Value Measurement Amid Market Disruption

Transatlantic Panic: The State of Finance Today in the EU

The SEC Marches Forward with its Disclosure Effectiveness Program

The (Mario) Party’s Over: Nintendo’s Data Breach

The Importance of Equity Compensation Accounting During Uncertain Times

First Quarter COVID-19 Disclosure Examples – Part Two

Hitting the Books with Prof. Bill Dilla: Part Two

Hitting the Books with Prof. Bill Dilla: Part One

Eerie Accountancy: The Whistling Weakness

SEC and PCAOB Issue Statement About Emerging Market Investments

The SEC Professionals Group and Examples of COVID-19’s Disclosure Impact

The CECL, CARES, and Coronavirus Conundrum

FASB Addresses Impact of COVID-19 and Publishes Lease Accounting Q&A

A Few Example Proxies for Virtual Annual Meetings

An Example of COVID-19 Forewarning Disclosures

SEC Chair and Corp Fin Director Issue Statement About COVID-19 Disclosure

SEC Updates Staff Guidance for Conducting Shareholder Meetings in Light of COVID-19 Concerns

An SEC PCAOB? OMG!

SEC Issues Two C&DI’s Dealing with COVID-19 Deadline Relief

SEC Chief Accountant Issues COVID-19 Statement Including CECL Considerations

inSecurities Podcast

SEC Issues Two C&DI’s Dealing with COVID-19 Deadline Relief

How Do We Prepare For the Next Time This Happens?

What to do when your coworkers are cats

Is COVID-19 a Triggering Event for Impairment Testing?

Interim Impairment Testing: Financial Reporting Insight

A Brief Update on Financial Reporting Valuations During the COVID-19 Crisis

What Happens If I Can’t Meet my SEC Filing Deadlines?